More about
Metastatic Castration-Sensitive Prostate Cancer
News
August 02, 2023
3 min read
Save
‘Equitable access’ to care may reduce racial disparities in prostate cancer survival
Black men with metastatic castration-sensitive prostate cancer achieved OS and PFS comparable to white men when treated in a clinical trial setting, according to results of the randomized phase 3 SWOG 1216 trial.
News
December 17, 2019
1 min read
Save
FDA approves Xtandi for metastatic castration-sensitive prostate cancer
The FDA approved enzalutamide for the treatment of metastatic castration-sensitive prostate cancer.